Search results for "PLASMA"

showing 10 items of 4043 documents

Plasma sublimation for the treatment of xanthelasma palpebrarum

2020

Introduction Xanthelasma palpebrarum (XP) is a common xanthomatous lesion of the eyelid and periorbital skin. Several methods of treatment have been reported in the literature, each having its own indications and risks. We present a new treatment method for removing XP using a plasma exeresis device (Plexr®, GMV, Italy). Methods Fifteen patients with a total of 27 treated XPs were assessed and clinically identified by the treating dermatologist. Patients were photographed and assessed by a dermatologist prior to and immediately after treatment. A patient survey was conducted 12 months after the procedure, which assessed the outcome of the procedure (redness, pigmentation disorders, and scar…

Malemedicine.medical_specialtyScarsPlasma Skin RegenerationDermatologyXanthomaLesionXanthomatosismedicineHumansPigmentation disorderAgedRetrospective Studiesbusiness.industryTreatment methodMiddle Agedmedicine.diseaseDermatologyTreatment OutcomeInfectious Diseasesmedicine.anatomical_structureXanthelasmaPatient SatisfactionEyelid DiseasesFemalePatient surveyLaser TherapyEyelidmedicine.symptombusinessActa Dermatovenerologica Alpina Pannonica et Adriatica
researchProduct

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

2018

There is scarcity of information about the hemorheological pattern in subjects with Monoclonal Gammopathy of Undetermined Significance (MGUS). This preliminary research is focused on the behaviour of whole-blood and plasma viscosity, haematocrit and erythrocyte deformability in the above clinical condition. We enrolled 21 MGUS subjects (10 women and 11 men; mean age 66.4 ± 11.6 years). In fasting venous blood we examined whole-blood and plasma viscosity at high and low shear rates, haematocrit, the ratios between whole-blood viscosity (at high and low shear rate) and haematocrit × 100, the ratio between plasma viscosity at low and high shear rate, and the erythrocyte deformability expressed…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyBlood viscosity030204 cardiovascular system & hematologyMonoclonal Gammopathy of Undetermined SignificanceSettore MED/15 - Malattie Del Sangue03 medical and health sciencesViscosity0302 clinical medicinehemic and lymphatic diseasesPhysiology (medical)Internal medicineErythrocyte DeformabilitymedicineErythrocyte deformabilityHumanscardiovascular diseasesPlasma viscosityParaproteinemia; blood viscosity; erythrocyte deformability; plasma viscosityAgedChemistryMean ageHematologyVenous bloodmedicine.diseaseBlood ViscosityShear rateParaproteinemiaEndocrinology030220 oncology & carcinogenesisplasma viscosityFemaleCardiology and Cardiovascular MedicineRheologyMonoclonal gammopathy of undetermined significanceClinical hemorheology and microcirculation
researchProduct

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

2012

ObjectivesThis study sought to investigate plasma levels of circulating cardiac natriuretic peptides, atrial natriuretic peptide (ANP) and B-type or brain natriuretic peptide (BNP), in the general community, focusing on their relative differences in worsening human hypertension.BackgroundAlthough ANP and BNP are well-characterized regulators of blood pressure in humans, little is known at the population level about their relationship with hypertension. The authors hypothesized that hypertension is associated with a lack of activation of these hormones or their molecular precursors.MethodsThe study cohort (N = 2,082, age >45 years) was derived from a random sample from Rochester, Minnesota, …

Malemedicine.medical_specialtySettore MED/09 - Medicina Internahypertensionmedicine.drug_class030204 cardiovascular system & hematologyCardiac hormonesArticle03 medical and health sciences0302 clinical medicineAtrial natriuretic peptideInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseasesBNP; ANP; Human HypertensionAged030304 developmental biology0303 health sciencesnatriuretic peptideExtramuralbusiness.industryPlasma levelsMiddle AgedBrain natriuretic peptideSettore MED/11 - Malattie Dell'Apparato CardiovascolareproBNPEndocrinologyNT-proBNPHuman HypertensionLinear Modelscardiovascular systemFemaleCardiology and Cardiovascular MedicinebusinessAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistsANPcirculatory and respiratory physiologyBNPJournal of the American College of Cardiology
researchProduct

Plasma myeloperoxidase levels in acute brain ischaemia and high grade carotid stenosis.

2020

Myeloperoxidase (MPO) is an important oxidative enzyme participating in different stages of cardiovascular disease and predicts prognosis. Little is known about its role in acute cerebrovascular events and carotid plaque vulnerability. In this study, the aim was to assess plasma MPO levels in acute stroke patients and their correlation to stroke severity and stroke outcome.Plasma MPO levels were assessed in patients presenting with acute brain ischaemia within 36 h of symptom onset (n = 144, mean age 64.7 ± 11.6 years, 67% men) and in patients with moderate-to-severe carotid stenosis undergoing carotid artery stenting (n = 51, mean age 66.3 ± 8.4 years, 75% men). Patients presenting with ac…

Malemedicine.medical_specialtyStroke severityDiseaseBrain Ischemia03 medical and health sciencesPlasma0302 clinical medicineModified Rankin ScaleInternal medicineIschaemic strokemedicineHumansIn patientCarotid Stenosiscardiovascular diseases030212 general & internal medicineStrokeAgedPeroxidasebiologybusiness.industryMiddle Agedmedicine.diseaseStrokeStenosisTreatment OutcomeNeurologyMyeloperoxidaseCardiologybiology.proteinFemaleNeurology (clinical)business030217 neurology & neurosurgeryEuropean journal of neurologyReferences
researchProduct

Clozapine plasma level monitoring for prediction of rehospitalization schizophrenic outpatients.

2011

INTRODUCTION: The aim of this naturalistic exploratory study was to examine whether blood antipsychotic drug concentrations can predict rehospitalizations in chronically medicated patients. METHODS: The study included schizophrenic outpatients under clozapine (CLZ) maintenance treatment, supervised by therapeutic drug monitoring (TDM). Patients were observed for a period of 21 months. Their on average monthly measured plasma levels and the date of rehospitalizations were recorded. The variability of the first 3 CLZ plasma levels, measured in 3.6 months, was compared between patients with and without rehospitalization. RESULTS: 23 patients participated of which 6 patients were rehospitalized…

Malemedicine.medical_specialtyTime FactorsPatient ReadmissionMaintenance therapyRecurrenceInternal medicineOutpatientsmedicineHumansPharmacology (medical)In patientAntipsychotic drugClozapineClozapinemedicine.diagnostic_testbusiness.industryGeneral MedicinePlasma levelsmedicine.diseaseSurgeryHospitalizationPsychiatry and Mental healthSchizophreniaTherapeutic drug monitoringPlasma concentrationSchizophreniaFemaleDrug Monitoringbusinessmedicine.drugAntipsychotic AgentsPharmacopsychiatry
researchProduct

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treate…

2021

Background We assessed the impact of preprocedural plasma levels of MRproANP (midregional N‐terminal pro–atrial natriuretic peptide) and sST2 (soluble suppression of tumorigenicity 2) on recurrence of atrial fibrillation (AF) at 1 year after catheter ablation of AF. Methods and Results This was a prospective, multicenter, observational study including patients undergoing catheter ablation of AF. MRproANP and sST2 were measured in a peripheral venous blood preprocedure, and MRproANP was assessed in the right and left atrial blood during ablation. The primary end point was recurrent AF between 3 and 12 months postablation, defined as a documented (>30 seconds) episode of AF, flutter, or a…

Malemedicine.medical_specialtyTime Factorsmedicine.drug_classmedicine.medical_treatmentBiorhythmCatheter ablation030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineHeart RatePredictive Value of TestsRecurrenceRisk FactorsInternal medicinecatheter ablationAtrial FibrillationmedicineNatriuretic peptideHumansIn patientArrhythmia and Electrophysiology030212 general & internal medicineHeart AtriaProspective StudiesOriginal ResearchAgedsST2business.industryMRproANPbiomarkersAtrial fibrillationPlasma levelsMiddle Agedmedicine.diseaseInterleukin-1 Receptor-Like 1 ProteinUp-RegulationHeart RhythmTreatment OutcomePro atrial natriuretic peptideCardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessCatheter Ablation and Implantable Cardioverter-DefibrillatorAtrial Natriuretic FactorJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
researchProduct

Long-Term Effects of Dietary Sodium Intake on Cytokines and Neurohormonal Activation in Patients With Recently Compensated Congestive Heart Failure

2009

Abstract Background A growing body of evidence suggests that the fluid accumulation plays a key role in the pathophysiology of heart failure (HF) and that the inflammatory and neurohormonal activation contribute strongly to the progression of this disorder. Methods and Results The study evaluated the long-term effects of 2 different sodium diets on cytokines neurohormones, body hydration and clinical outcome in compensated HF outpatients (New York Heart Association Class II). A total of 173 patients (105 males, mean age 72.5±7) recently hospitalized for worsening advanced HF and discharged in normal hydration and in clinical compensation were randomized in 2 groups (double blind). In Group …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPlasma renin activityGastroenterologychemistry.chemical_compoundDouble-Blind MethodInternal medicinemedicineHumansAgedAged 80 and overHeart FailureNeurotransmitter AgentsAldosteronebusiness.industryFurosemideSodium Dietarymedicine.diseaseBrain natriuretic peptidePathophysiologyAldosterone BNP bioelectrical impedance congestive heart failure cytochines plasma renin activatityEndocrinologyCytokinechemistryHeart failureCytokinesFemaleDiureticCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugFollow-Up Studies
researchProduct

Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding

2007

The objective of this paper was to characterize the disposition phase of AM in rats, after different high doses and modalities of i.v. administration. Three fitting programs, WINNONLIN, ADAPT II and NONMEM were employed. The two-stage fitting methods led to different results, none of which can adequately explain amiodarone's behaviour, although a great amount of data per subject is available. The non-linear mixed effect modelling approach allows satisfactory estimation of population pharmacokinetic parameters, and their respective variability. The best model to define the AM pharmacokinetic profile is a two-compartment model, with saturable and dynamic plasma protein binding and linear tiss…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationAmiodaronePharmaceutical SciencePharmacologyAntiarrhythmic agentAmiodaroneModels BiologicalPharmacokineticsInternal medicineBlood plasmaAnimalsMedicineTissue DistributionDosingRats Wistareducationeducation.field_of_studyDose-Response Relationship Drugbusiness.industryBlood ProteinsBlood proteinsRatsNONMEMEndocrinologyArea Under CurveData Interpretation StatisticalInjections IntravenousbusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

Bromocriptine and Prostatic Carcinoma: Plasma Kinetics, production and Tissue Uptake of3H-Testosterone in Vivo

1978

The influence of the anti-prolactin bromocriptine on plasma kinetics, production rate and tissue uptake of testosterone was investigated in 15 patients with newly diagnosed stages C and D prostatic carcinoma. Bromocriptine was given for 5 days in a daily dose of 15 mg. orally. The studies were performed with the single injection technique using the 2-compartment model. Plasma testosterone, serum prolactin, and luteinizing and follicle-stimulating hormones were determined initially. Blood samples were drawn up to 5 hours after the injection of 3H-testosterone. For tissue studies a transrectal needle biopsy was done 3 hours post-injection. Bromocriptine suppressed prolactin and the endogenous…

Malemedicine.medical_specialtyUrologyEndogenyIn vivoInternal medicinemedicineCarcinomaHumansTestosteroneBromocriptineAgedbusiness.industryBiopsy NeedleProstatic NeoplasmsLuteinizing Hormonemedicine.diseaseBromocriptineProlactinProlactinKineticsPlasma kineticsEndocrinologyNeedle biopsyFollicle Stimulating HormonebusinessHormonemedicine.drugJournal of Urology
researchProduct

Influence of lipids on blood and plasma viscosity.

2014

Amparo Vayaa,∗, Cristina Gimeneza, Rafael Alisb,c, Julian Muradoa and Oscar Fustera aHemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain bResearch Universitary Institute “Dr. Vina Giner”, Molecular and Mitochondrial Medicine, Catholic University of Valencia “San Vicente Martir”, Valencia, Spain cFaculty of Medicine, Catholic University of Valencia “San Vicente Martir”, Valencia, Spain

Malemedicine.medical_specialtybiologyPhysiologybusiness.industryHematologybiology.organism_classificationUniversity hospitalLipidsPhysiology (medical)Family medicineHemorheologymedicineHumansFemaleCardiology and Cardiovascular MedicinePlasma viscositybusinessValenciaClinical hemorheology and microcirculation
researchProduct